Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment
- 1 October 1996
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 126 (2) , 305-312
- https://doi.org/10.1016/0021-9150(96)05919-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischemiaFree Radical Biology & Medicine, 1994
- Formation of PGF2-Isoprostanes During the Oxidative Modification of Low Density LipoproteinBiochemical and Biophysical Research Communications, 1994
- Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?Kidney International, 1994
- Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic riskCoronary Artery Disease, 1993
- Low-density lipoprotein oxidation in essential hypertensionJournal Of Hypertension, 1993
- Autoantibody against oxidised LDL and progression of carotid atherosclerosisThe Lancet, 1992
- A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.Proceedings of the National Academy of Sciences, 1990
- Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.Journal of Clinical Investigation, 1989
- Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.Proceedings of the National Academy of Sciences, 1987
- The Low-Density Lipoprotein Pathway and its Relation to AtherosclerosisAnnual Review of Biochemistry, 1977